FET: III: Small: Innovative Approaches for Bias Correction and Systems-level Analysis in Integrated Multi-omics Data
FET: III: Small: Innovative Approaches for Bias Correction and Systems-level Analysis in Integrated Multi-omics Data
批准号:
2203236
负责人:
Juli Petereit
金额:
$60.0万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2025-06-30
中文摘要
识别受影响的途径和生物过程中的变化是重要的,因为它提供了对生物学基础条件的洞察,而不仅仅是对差异表达基因的检测。由于这种分析的重要性,迄今为止已经开发了100多种途径分析方法。然而,由于所有这些方法都偏向于研究充分的条件,如癌症疾病,通路分析方法的准确性严重受损,特别是在研究非癌症疾病和表型时。更重要的是,现有方法仅限于对单一队列或数据类型的分析,使其对生物异质性敏感,无法分析涉及多个分子水平的复杂疾病。该项目旨在通过设计一个分析管道来弥合这些差距,该管道将在一个计算框架中解决偏差校正和数据集成问题。这将对许多研究和公共卫生领域产生重大影响,有助于查明假定的疾病分子原因,以及查明潜在的治疗干预措施及其可能的副作用。该项目还包括一个系统的外展计划,涉及内华达州的主要本科院校(PUI),特别是少数民族和西班牙裔服务机构:南内华达学院和内华达州立学院。这里介绍的应用程序将使学生无需进行湿实验室实验就能进行令人兴奋的科学研究。其他计划的外展活动包括为华肖县学区的K-12当地学校举办的暑期讲习班。大多数路径注释数据库都有重要的局限性。其中一些限制与领域有关(例如,只关注癌症),另一些限制与所包含的数据类型有关(例如,只关注表达数据),还有一些限制与所选择的描述现象的细节水平有关。此外,由于不切实际的假设和过度拟合,路径分析方法受到系统偏差的影响。另一个痛点是无法在同一分析中轻松包含多个队列和多种类型的组学数据。该项目将提供一个框架,允许研究人员在纠正方法偏差和整合多种数据类型和数据集的同时保留他们首选的路径方法。该项目的目标将通过两个重点来实现:1)设计一种偏差校正和路径方法共识分析的方法;2)开发一种灵活整合多队列和多组学数据的新方法。该框架的设计将使其能够与任何现有的路径分析方法结合使用,以纠正偏差,纳入来自不同数据库的知识并整合不同类型的数据。该项目还包括使用100多个具有已知机制的数据集对拟议方法进行系统评估计划。研究小组将提供一种实现,支持许多模式生物广泛使用的几种方法。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
Identifying impacted pathways and changes in biological processes is important because it provides insights into the biology underlying conditions beyond the detection of differentially expressed genes. Because of the importance of such analysis, more than 100 pathway-analysis methods have been developed thus far. However, as all these methods are biased toward well-studied conditions, such as cancer diseases, the accuracy of pathway-analysis methods is severely compromised, especially when investigating non-cancer diseases and phenotypes. More importantly, existing methods are limited to the analysis of a single cohort or data type, making them sensitive to biological heterogeneity and unable to analyze complex diseases that involve multiple molecular levels. This project aims to bridge these gaps by designing an analysis pipeline that will tackle bias correction and data integration in one computational framework. This will have a great impact in many research and public health areas by facilitating the identification of putative molecular causes of disease, as well as the identification of potential therapeutic interventions and their possible side effects. This project also includes a systematic outreach program involving Primarily Undergraduate Institutions (PUI) across Nevada, especially minority- and Hispanic-serving institutions: College of Southern Nevada and Nevada State College. The applications presented here will enable students to conduct exciting scientific research without the need to perform wet-lab experiments. Other planned outreach activities involve summer workshops for K-12 local schools from Washoe County School District. Most pathway-annotation databases have important limitations. Some of these limitations are related to the domain (e.g., focused on cancer alone), others to the types of data included (e.g., only expression data), and still others to the level of detail chosen to describe the phenomenon. Further, pathway-analysis methods are subject to systematic bias due to unrealistic assumptions and overfitting. Another pain point is the inability to easily include multiple cohorts and multiple types of -omics data in the same analysis. This project will provide a framework that allows researchers to retain their preferred pathway methods while correcting for method bias and integrating multiple data types and datasets. The goal of this project will be achieved by two thrusts: 1) design a methodology for bias correction and consensus analysis of pathway methods, and 2) develop a novel approach for the flexible integration of multi-cohort and multi-omics data. The framework will be designed so that it can be applied in conjunction with any existing pathway-analysis method to correct for bias, incorporate knowledge from different databases and integrate data of different types. The project also includes a systematic evaluation plan of the proposed methodologies using more than 100 datasets with known mechanisms. The research team will deliver an implementation that supports several widely used methods for many model organisms.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DWEN: A novel method for accurate estimation of cell type compositions from bulk data samples
DWEN:一种从大量数据样本中准确估计细胞类型组成的新方法
DOI:
10.1109/kse56063.2022.9953757
发表时间:
2022
期刊:
2022 14th International Conference on Knowledge and Systems Engineering (KSE
影响因子:
--
作者:
[Tran, Duc, Nguyen, Ha, Nguyen, Hung, Nguyen, Tin]
通讯作者:
Nguyen, Tin
国内基金
海外基金
登录
查看更多内容
基于人工智能与多组学的III期结核性脓胸CT“低密度线”形成机制及手术时机预测模型研究
-
批准号:JCZRMS202602483
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于MOF–CRISPR微流控平台的雄黄As(III)/As(V)价态识别与炮制耦合机制研究
-
批准号:JCZRLH202600780
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白术内酯III靶向IRF4-CD36轴通过调控脂质代谢重编程提升结直肠癌奥沙利铂敏感性的机制研究
-
批准号:2026JJ82690
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张卓
-
依托单位:
基于废水零排放的FeS-As(III)置换法从污酸中清洁脱砷处理技术研究
-
批准号:2026JJ30130
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张二军
-
依托单位:
全钒液流电池负极V(II)/V(III)电化学氧化还原的催化机理研究
-
批准号:2025JJ50094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王珏
-
依托单位:
猪纤维蛋白粘合剂预防胸外科术后漏气的适应症拓展研究:一项多中心、随机对照III期临床试验
-
批准号:25SF1901800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵德平
-
依托单位:
HOXC8/OPN/CD44/EGFR轴介导的奥沙利铂耐药性在III期右半结肠癌耐药进展中的研究
-
批准号:2025JJ50694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:喻南慧
-
依托单位:
MXene/nZVI@FH材料微域层界面调控水中砷(III)氧化迁移机制
-
批准号:2025JJ50319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈润华
-
依托单位:
硅基III-V族亚微米线激光器的光场模式调控与耦合机理研究
-
批准号:JCZRQN202501004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
吡咯烷生物碱所致肝窦阻塞综合征III区肝损伤的新机制——局部氨代谢紊乱
-
批准号:JCZRYB202500652
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: